Page last updated: 2024-09-03

lysyl-aspartyl-glutamyl-leucine and HIV Coinfection

lysyl-aspartyl-glutamyl-leucine has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Rosa, SC; Hamer, DH; Lueders, KK; Pavlakis, GN; Roederer, M; Valentin, A1

Other Studies

1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and HIV Coinfection

ArticleYear
A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types.
    AIDS research and human retroviruses, 2004, Volume: 20, Issue:2

    Topics: ADP Ribose Transferases; Animals; Antiretroviral Therapy, Highly Active; Bacterial Toxins; Cells, Cultured; Chemotherapy, Adjuvant; CHO Cells; Cricetinae; Exotoxins; Genes, Reporter; Green Fluorescent Proteins; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunotoxins; In Vitro Techniques; Leukocytes, Mononuclear; Luminescent Proteins; Lymphocyte Subsets; Oligopeptides; Protein Sorting Signals; Pseudomonas aeruginosa Exotoxin A; Virulence Factors

2004